Basic Information | Post buying leads | Suppliers |
Name |
Taspoglutide |
EINECS | N/A |
CAS No. | 275371-94-3 | Density | 1.46 |
PSA | 1385.09000 | LogP | 3.19740 |
Solubility | N/A | Melting Point |
N/A |
Formula | C152H232 N40 O45 | Boiling Point | N/A |
Molecular Weight | 3339.75 | Flash Point | N/A |
Transport Information | N/A | Appearance | N/A |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
BIM 51077;ITM 077;R 1583;RO 5073031;7-36-Glucagon-likepeptide I (human), 8-(2-methylalanine)-35-(2-methylalanine)-36-L-argininamide-; |
1. Introduction of Taspoglutide
Taspoglutide (CAS NO.275371-94-3), with its synonyms of 7-36-Glucagon-like peptide I (human), 8-(2-methylalanine)-35-(2-methylalanine)-36-L-argininamide-; H2N-His-2-methyl-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-2-methyl-Ala-Arg-CONH2, is one kind of fine chemical. Taspoglutide is a glucagon-like peptide-1 analog drug under investigation for treatment of type 2 diabetes being co-developed by Ipsen and Roche.